1. Home
  2. SCLX vs UBCP Comparison

SCLX vs UBCP Comparison

Compare SCLX & UBCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCLX
  • UBCP
  • Stock Information
  • Founded
  • SCLX 2011
  • UBCP 1902
  • Country
  • SCLX United States
  • UBCP United States
  • Employees
  • SCLX N/A
  • UBCP N/A
  • Industry
  • SCLX Biotechnology: Pharmaceutical Preparations
  • UBCP Major Banks
  • Sector
  • SCLX Health Care
  • UBCP Finance
  • Exchange
  • SCLX Nasdaq
  • UBCP Nasdaq
  • Market Cap
  • SCLX 81.7M
  • UBCP 77.3M
  • IPO Year
  • SCLX N/A
  • UBCP N/A
  • Fundamental
  • Price
  • SCLX $0.42
  • UBCP $12.78
  • Analyst Decision
  • SCLX Strong Buy
  • UBCP
  • Analyst Count
  • SCLX 3
  • UBCP 0
  • Target Price
  • SCLX $11.33
  • UBCP N/A
  • AVG Volume (30 Days)
  • SCLX 184.3K
  • UBCP 10.1K
  • Earning Date
  • SCLX 01-07-2025
  • UBCP 02-04-2025
  • Dividend Yield
  • SCLX N/A
  • UBCP 4.17%
  • EPS Growth
  • SCLX N/A
  • UBCP N/A
  • EPS
  • SCLX N/A
  • UBCP 1.37
  • Revenue
  • SCLX $50,833,000.00
  • UBCP $29,231,000.00
  • Revenue This Year
  • SCLX $32.77
  • UBCP N/A
  • Revenue Next Year
  • SCLX $50.71
  • UBCP $7.23
  • P/E Ratio
  • SCLX N/A
  • UBCP $9.35
  • Revenue Growth
  • SCLX 9.41
  • UBCP N/A
  • 52 Week Low
  • SCLX $0.40
  • UBCP $11.40
  • 52 Week High
  • SCLX $2.63
  • UBCP $15.50
  • Technical
  • Relative Strength Index (RSI)
  • SCLX 29.75
  • UBCP 44.47
  • Support Level
  • SCLX $0.43
  • UBCP $12.50
  • Resistance Level
  • SCLX $0.51
  • UBCP $14.10
  • Average True Range (ATR)
  • SCLX 0.06
  • UBCP 0.94
  • MACD
  • SCLX -0.01
  • UBCP -0.19
  • Stochastic Oscillator
  • SCLX 7.30
  • UBCP 12.28

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

About UBCP United Bancorp Inc.

United Bancorp Inc operates as a bank holding company that provides commercial and retail banking services. The company's primary deposit products are checking, savings and term certificate accounts and its primary lending products are residential mortgages, commercial and installment loans. The company serves customers mainly located in Athens, Belmont, Carroll, Fairfield, Harrison, Jefferson and Tuscarawas Counties in Ohio and Marshall and Ohio Counties in West Virginia and the surrounding localities in northeastern, east-central and southeastern Ohio and include a wide range of individuals, businesses and other organizations.

Share on Social Networks: